Villarin, Romeo .

HRN: 26-35-84  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2024
RIFAXIMIN 200MG (TAB)
12/12/2024
12/19/2024
PO
200mg
Tid
T/c Hepatic Enceph
Waiting Final Action 
12/12/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/12/2024
12/19/2024
IV
500mg
Q8
T/C Hepatic Enceph
Waiting Final Action 
12/21/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/21/2024
12/27/2024
IV
500mg
Q6h
H Pylori Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: